(Q35004356)

5 August 2017

title

Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment (English)

1 reference

5 August 2017

0 references

1 reference

M F Derbala

1

1 reference

5 August 2017

A M Amer

2

1 reference

5 August 2017

M Almohanadi

3

1 reference

5 August 2017

A John

4

1 reference

5 August 2017

A Amin

5

1 reference

5 August 2017

A John

6

1 reference

5 August 2017

M Sharma

7

1 reference

5 August 2017

S R Alkaabi

8

1 reference

5 August 2017

N Z Al Dweik

9

1 reference

5 August 2017

F Pasic

10

1 reference

5 August 2017

R Yaqoob

11

1 reference

5 August 2017

M T Butt

12

1 reference

5 August 2017

F M Shebl

13

1 reference

5 August 2017

publication date

25 November 2010

1 reference

Journal of Viral Hepatitis

5 August 2017

published in

1 reference

5 August 2017

volume

18

1 reference

5 August 2017

issue

7

1 reference

5 August 2017

page(s)

e258-62

1 reference

HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Platelet function and the von Willebrand factor antigen in the hepatosplenic form of schistosomiasis mansoni

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Thrombopoietin level in patients with chronic liver diseases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

The relationship of histologic activity to serum ALT, HCV genotype and HCV RNA titers in chronic hepatitis C

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Histological assessment of tissue repair after treatment of human schistosomiasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Distribution of hepatitis C virus RNA in the liver and its relation to histopathological changes.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Hepatitis C genotype 4: What we know and what we don't yet know.

8 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01403.X

Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01403.X

Predictors of histological activity and fibrosis in chronic Hepatitis C infection: a study from North India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01403.X

Re-evaluation of the serum alanine aminotransferase upper normal limit in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01403.X

Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01403.X

Interleukin-10 promoter polymorphisms in hepatitis C patients with and without Schistosoma mansoni co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01403.X

Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01403.X

Hepatitis C treatment response kinetics and impact of baseline predictors

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

Hepatitis C virus-infected patients with a persistently normal alanine aminotransferase: do they exist and is this really a group with mild disease?

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101275

[Replication of HCV in bone marrow of patients with haematological disorders]

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21108700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2893.2010.01403.X

1 reference

5 August 2017

1 reference

5 August 2017

1 reference